An Overview on the Clinical Development of Tau-Based Therapeutics-Reference-Cited by-同舟云学术

An Overview on the Clinical Development of Tau-Based Therapeutics

Published:2018-04-11 Issue:4 Volume:19 Page:1160
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Medina Miguel^ORCID

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/19/4/1160/pdf

Reference74 articles.

1. A protein factor essential for microtubule assembly.

2. Tau protein function in living cells.

3. Axonal Transport, Tau Protein, and Neurodegeneration in Alzheimer's Disease

4. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

5. Protein changes in senile dementia

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tau proteins and senescent Cells: Targeting aging pathways in Alzheimer’s disease;Brain Research;2024-12

2. Alzheimer’s disease: a review on the current trends of the effective diagnosis and therapeutics;Frontiers in Aging Neuroscience;2024-08-09

3. Progressive supranuclear palsy: Neuropathology, clinical presentation, diagnostic challenges, management, and emerging therapies;Disease-a-Month;2024-08

4. Oligodendrocyte Dysfunction in Tauopathy: A Less Explored Area in Tau-Mediated Neurodegeneration;Cells;2024-06-27

5. Targeted protein degradation in CNS disorders: a promising route to novel therapeutics?;Frontiers in Molecular Neuroscience;2024-04-15